衰弱与肌少症评估在胃肠道肿瘤术后结局预测中的应用与展望

doi:10.6040/j.issn.1671-7554.0.2024.1231

摘要/Abstract

摘要： 衰弱和肌少症是胃肠道肿瘤患者术前常见的并存状态,通过炎症通路和代谢异常机制相互作用,显著增加术后并发症和死亡风险。然而,目前针对衰弱与肌少症的评估工具多独立开展,尚缺乏联合评估的统一体系。本研究系统梳理了衰弱与肌少症的诊断方法及其在胃肠道肿瘤患者术后结局预测中的应用,并强调早期识别与干预的重要性,但区域性限制和评估工具差异性仍需未来多中心研究进一步验证。结合人工智能的精准预测模型将为优化干预方案和改善患者预后提供新方向,为围手术期管理和临床决策带来新的思路。

关键词: 衰弱, 肌少症, 胃肠道肿瘤, 围手术期管理, 人工智能预测模型, 临床营养

Abstract: Frailty and sarcopenia are common comorbidities in patients with gastrointestinal tumours before surgery. Through mechanisms involving inflammatory pathways and metabolic abnormalities, these conditions significantly increase the risk of postoperative complications and mortality. However, current assessment tools for frailty and sarcopenia are often used independently, and a unified system for combined assessment is still lacking. This study systematically reviews the diagnostic methods for frailty and sarcopenia and their application in predicting postoperative outcomes in patients with gastrointestinal tumours, highlighting the importance of early detection and intervention. Despite its innovative nature, this study is limited by regional limitations and variability in assessment tools, which require further validation through future multicentre studies. The integration of precision prediction models based on artificial intelligence offers a new direction for optimising intervention strategies and improving patient outcomes, so as to provide novel insights for perioperative management and clinical decision-making.

Key words: Frailty, Sarcopenia, Gastrointestinal tumours, Perioperative management, AI forecasting model, Clinical nutrition

中图分类号:

R735.2

王宝炫,焦杰,张厚君,刘奇,于冠英. 衰弱与肌少症评估在胃肠道肿瘤术后结局预测中的应用与展望[J]. 山东大学学报 (医学版), 2025, 63(4): 51-58.

WANG Baoxuan, JIAO Jie, ZHANG Houjun, LIU Qi, YU Guanying. Application and perspectives of frailty and sarcopenia assessment in predicting postoperative outcomes of gastrointestinal tumours[J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 51-58.

参考文献

[1] Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J, 2021, 134(7): 783-791.
[2] Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
[3] Chen CC, Chen CN, Lai IR, et al. Effects of a modified Hospital Elder Life Program on frailty in individuals undergoing major elective abdominal surgery[J]. J Am Geriatr Soc, 2014, 62(2): 261-268.
[4] Kim EY, Kim K, Kim YS, et al. Prevalence of and factors associated with sarcopenia in Korean cancer survivors: based on data obtained by the Korea national health and nutrition examination survey(KNHANES)2008-2011[J]. Nutr Cancer, 2017, 69(3): 394-401.
[5] Sousa IM, Silva FM, das Virgens IPA, et al. Independent and joint association of sarcopenia and frailty with mortality in older patients with gastrointestinal cancer: a cohort study with prospective data collection[J]. Support Care Cancer, 2023, 31(12): 728. doi:10.1007/s00520-023-08173-9
[6] Hoogendijk EO, Afilalo J, Ensrud KE, et al. Frailty: implications for clinical practice and public health[J]. Lancet, 2019, 394(10206):1365-1375.
[7] Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action[J]. J Am Med Dir Assoc, 2013, 14(6): 392-397.
[8] Hartley P, Adamson J, Cunningham C, et al. Clinical frailty and functional trajectories in hospitalized older adults: a retrospective observational study[J]. Geriatr Gerontol Int, 2017, 17(7): 1063-1068.
[9] Kua J, Ramason R, Rajamoney G, et al. Which frailty measure is a good predictor of early post-operative complications in elderly hip fracture patients?[J]. Arch Orthop Trauma Surg, 2016, 136(5): 639-647.
[10] Goede V. Frailty and cancer: current perspectives on assessment and monitoring[J]. Clin Interv Aging, 2023, 18: 505-521. doi:10.2147/CIA.S365494
[11] McIsaac DI, Wong CA, Huang A, et al. Derivation and validation of a generalizable preoperative frailty index using population-based health administrative data[J]. Ann Surg, 2019, 270(1): 102-108.
[12] McIsaac DI, MacDonald DB, Aucoin SD. Frailty for perioperative clinicians: a narrative review[J]. Anesth Analg, 2020, 130(6): 1450-1460.
[13] McIsaac DI, Taljaard M, Bryson GL, et al. Frailty as a predictor of death or new disability after surgery: a prospective cohort study[J]. Ann Surg, 2020, 271(2): 283-289.
[14] McIsaac DI, Beaulé PE, Bryson GL, et al. The impact of frailty on outcomes and healthcare resource usage after total joint arthroplasty[J]. Bone Jt J, 2016, 98-B(6): 799-805.
[15] Robinson TN, Wu DS, Stiegmann GV, et al. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults[J]. Am J Surg, 2011, 202(5): 511-514.
[16] Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review[J]. Eur J Intern Med, 2016, 31: 3-10. doi:10.1016/j.ejim.2016.03.007
[17] 杨淦, 李小明, 曹星琦, 等. 我国老年人群衰弱不同测量方法的比较分析——基于江苏省如皋市某镇2021年调查[J]. 中国医学前沿杂志(电子版), 2023, 15(10): 49-60. YANG Gan, LI Xiaoming, CAO Xingqi, et al. Comparison of different frailty measurements among Chinese elderly population based on the 2021 survey in one town of Rugao City, Jiangsu Province[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2023, 15(10): 49-60.
[18] 李明妍, 王睿哲, 易莹莹, 等. 癌症病人衰弱评估工具的研究进展[J]. 护理研究, 2024, 38(15): 2723-2727. LI Mingyan, WANG Ruizhe, YI Yingying, et al. Research progress on frailty assessment tools for cancer patients[J]. Chinese Nursing Research, 2024, 38(15): 2723-2727.
[19] 倪微, 马影蕊. 老年衰弱评估工具及其研究进展[J]. 智慧健康, 2024, 10(9): 33-40. NI Wei, MA Yingrui. Assessment tools and research progress of elderly frailty[J]. Smart Healthcare, 2024, 10(9): 33-40.
[20] Shaw JF, Budiansky D, Sharif F, et al. The association of frailty with outcomes after cancer surgery: a systematic review and metaanalysis[J]. Ann Surg Oncol, 2022, 29(8): 4690-4704.
[21] Panayi AC, Foroutanjazi S, Parikh N, et al. The modified 5-item frailty index is a predictor of perioperative risk in breast reconstruction: an analysis of 40, 415 cases[J]. J Plast Reconstr Aesthet Surg, 2022, 75(9): 2941-2954.
[22] Ng SC, Wong SH. Colorectal cancer screening in Asia[J]. Br Med Bull, 2013, 105: 29-42. doi:10.1093/bmb/lds040
[23] Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people[J]. Age Ageing, 2010, 39(4): 412-423.
[24] Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia[J]. J Cachexia Sarcopenia Muscle, 2016, 7(5): 512-514.
[25] 中国抗癌协会肿瘤营养与支持治疗专业委员会. 肌肉减少症营养治疗指南[J]. 肿瘤代谢与营养电子杂志, 2015, 2(3): 32-36.
[26] Voulgaridou G, Tyrovolas S, Detopoulou P, et al. Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the up-to-date evidence[J]. Nutrients, 2024, 16(3): 436. doi:10.3390/nu16030436
[27] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(4): 601. doi:10.1093/ageing/afz046
[28] Weng SE, Huang YW, Tseng YC, et al. The evolving landscape of sarcopenia in Asia: a systematic review and meta-analysis following the 2019 Asian working group for sarcopenia(AWGS)diagnostic criteria[J]. Arch Gerontol Geriatr, 2025, 128: 105596. doi:10.1016/j.archger.2024.105596
[29] 甄志龙, 赵建民, 孙逊, 等. 肌少症的诊疗共识解读与研究进展[J]. 生物骨科材料与临床研究, 2023, 20(1): 71-75. ZHEN Zhilong, ZHAO Jianmin, SUN Xun, et al. Progress of sarcopenia: diagnosis, treatment and research progress[J]. Orthopaedic Biomechanics Materials and Clinical Study, 2023, 20(1): 71-75.
[30] Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307.
[31] 刘娟, 丁清清, 周白瑜, 等. 中国老年人肌少症诊疗专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(8): 943-952. LIU Juan, DING Qingqing, ZHOU Baiyu, et al. Chinese expert consensus on diagnosis and treatment for elderly with sarcopenia(2021)[J]. Chinese Journal of Geriatrics, 2021, 40(8): 943-952.
[32] Soria-Utrilla V, Sánchez-Torralvo FJ, Palmas-Candia FX, et al. AI-assisted body composition assessment using CT imaging in colorectal cancer patients: predictive capacity for sarcopenia and malnutrition diagnosis[J]. Nutrients, 2024, 16(12): 1869. doi:10.3390/nu16121869
[33] Borggreve AS, den Boer RB, van Boxel GI, et al. The predictive value of low muscle mass as measured on CT scans for postoperative complications and mortality in gastric cancer patients: a systematic review and meta-analysis[J]. J Clin Med, 2020, 9(1): 199. doi:10.3390/jcm9010199
[34] Ye L, Liang R, Liu XL, et al. Frailty and sarcopenia: a bibliometric analysis of their association and potential targets for intervention[J]. Ageing Res Rev, 2023, 92: 102111. doi:10.1016/j.arr.2023.102111
[35] Marzetti E, Lees HA, Wohlgemuth SE, et al. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction[J]. Biofactors, 2009, 35(1): 28-35.
[36] Sasako T, Ueki K. Sarcopenia: loss of mighty armor against frailty and aging[J]. J Diabetes Investig, 2023, 14(10): 1145-1147.
[37] Landi F, Calvani R, Cesari M, et al. Sarcopenia as the biological substrate of physical frailty[J]. Clin Geriatr Med, 2015, 31(3): 367-374.
[38] Nascimento CM, Ingles M, Salvador-Pascual A, et al. Sarcopenia, frailty and their prevention by exercise[J]. Free Radic Biol Med, 2019, 132: 42-49. doi:10.1016/j.freeradbiomed.2018.08.035
[39] Wagner D, DeMarco MM, Amini N, et al. Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery[J]. World J Gastrointest Surg, 2016, 8(1): 27-40.
[40] Picca A, Coelho-Junior HJ, Calvani R, et al. Biomarkers shared by frailty and sarcopenia in older adults: a systematic review and meta-analysis[J]. Ageing Res Rev, 2022, 73: 101530. doi:10.1016/j.arr.2021.101530
[41] Piotrowicz K, Gsowski J, Michel JP, et al. Post-COVID-19 acute sarcopenia: physiopathology and management[J]. Aging Clin Exp Res, 2021, 33(10): 2887-2898.
[42] Li G, Fan YH, Lai YN, et al. Coronavirus infections and immune responses[J]. J Med Virol, 2020, 92(4): 424-432.
[43] 张伟, 李国立, 黎介寿. 胃肠道恶性肿瘤病人的围手术期营养支持治疗[J]. 肠外与肠内营养, 2016, 23(6): 326-328.
[44] Ligthart-Melis GC, Luiking YC, Kakourou A, et al. Frailty, sarcopenia, and malnutrition frequently(co-)occur in hospitalized older adults: a systematic review and meta-analysis[J]. J Am Med Dir Assoc, 2020, 21(9): 1216-1228.
[45] 陈路川, 滕文浩, 魏晟宏. 美国国家综合癌症网络胃癌临床实践指南(2022·V2)更新要点及解读[J]. 临床外科杂志, 2022, 30(9): 801-804. CHEN Luchuan, TENG Wenhao, WEI Shenghong. Update and interpretation of gastric cancer clinical practice guidelines of the National Comprehensive Cancer Network(2022. V2)[J]. Journal of Clinical Surgery, 2022, 30(9): 801-804.
[46] Dalton A, Zafirova Z. Preoperative management of the geriatric patient: frailty and cognitive impairment assessment[J]. Anesthesiol Clin, 2018, 36(4): 599-614.
[47] Tan ZKK, Tang WZ, Jia K, et al. Relation between frailty and adverse outcomes in elderly patients with gastric cancer: a scoping review[J]. Ann Med Surg, 2024, 86(3): 1590-1600.
[48] McGovern J, Grayston A, Coates D, et al. The relationship between the modified frailty index score(mFI-5), malnutrition, body composition, systemic inflammation and short-term clinical outcomes in patients undergoing surgery for colorectal cancer[J]. BMC Geriatr, 2023, 23(1): 9. doi:10.1186/s12877-022-03703-2
[49] Tang WZ, Tan ZKK, Qiu LY, et al. Prevalence and unfavorable outcome of frailty in older adults with gastric cancer: a systematic review and meta-analysis[J]. Support Care Cancer, 2024, 32(2): 115.
[50] 马旭, 李青科, 何立芳. 结直肠癌患者肌少症的发生率及其对术后感染和住院时间的影响[J]. 现代肿瘤医学, 2022, 30(13): 2400-2404. MA Xu, LI Qingke, HE Lifang. Characteristics of sarcopenia in patients with colorectal cancer and its influence on post-operative infection and hospital stay[J]. Journal of Modern Oncology, 2022, 30(13): 2400-2404.
[51] 梁枫, 苏飞雁. 肌肉减少症对结直肠癌患者术后并发症及预后影响的Meta分析[J]. 当代护士(中旬刊), 2021, 28(8): 12-16.
[52] Richards SJG, Senadeera SC, Frizelle FA. Sarcopenia, as assessed by psoas cross-sectional area, is predictive of adverse postoperative outcomes in patients undergoing colorectal cancer surgery[J]. Dis Colon Rectum, 2020, 63(6): 807-815.
[53] Chen F, Chi JT, Liu Y, et al. Impact of preoperative sarcopenia on postoperative complications and prognosis of gastric cancer resection: a meta-analysis of cohort studies[J]. Arch Gerontol Geriatr, 2022, 98: 104534. doi:10.1016/j.archger.2021.104534
[54] Osaki T, Tatebe S, Orihara J, et al. Impact of frailty and sarcopenia on short- and long-term outcomes in elderly patients undergoing radical gastrectomy for gastric cancer[J]. World J Surg, 2023, 47(12): 3250-3261.
[55] Aguilar-Frasco JL, Moctezuma-Velázquez P, Rodríguez-Quintero JH, et al. Preoperative frailty assessment in older patients with colorectal cancer: use of clinical and radiological tool[J]. Langenbecks Arch Surg, 2023, 408(1): 19. doi:10.1007/s00423-023-02754-2
[56] Lan QQ, Guan XC, Lu SZ, et al. Radiomics in addition to computed tomography-based body composition nomogram may improve the prediction of postoperative complications in gastric cancer patients[J]. Ann Nutr Metab, 2022, 78(6): 316-327.
[57] 高树庚. 加速康复外科在肺癌围术期管理中的应用[J]. 山东大学学报(医学版), 2022, 60(11): 1-10. GAO Shugeng. Application of enhanced recovery after surgery in perioperative management of lung cancer[J]. Journal of Shandong University(Health Sciences), 2022, 60(11): 1-10.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed